Javascript must be enabled to continue!
Studies in Acute Iron Poisoning. I. Desferrioxamine in the Treatment of Acute Iron Poisoning: Clinical Observations, Experimental Studies, and Theoretical Considerations, by Charles F. Whitten et al,Pediatrics, 1965;36:322–335; andStudies in Acute Iron Po
View through CrossRef
Objective. Children with iron poisoning, and mongrel dogs studied under laboratory conditions, were evaluated to explore the safety and effectiveness of the use of desferrioxamine in acute iron intoxication as reported in the 1965 paper.Methodology. Twelve children admitted to a pediatric unit after iron ingestion were subjected to gastric lavage (10) and treatment either with intravenous desferrioxamine (9) or with a combination of intravenous and enteral (gavage) desferrioxamine (3). Serum iron levels before and after therapy, urinary excretion of iron, and symptoms before and after therapy were all measured.Mongrel dogs (23) were fasted overnight and then given toxic doses of ferrous sulfate intraduodenally under general anesthesia. Controls (14) were observed for serum iron, arterial pH, and hematocrit, and mean arterial blood pressures. The 9 dogs treated were given desferrioxamine both intravenously and intraduodenally, whereas the controls were observed without treatment. Four additional dogs were treated with a lethal dose of iron that was first complexed with desferrioxamine and then administered intraduodenally. Another 2 dogs received a slow intravenous infusion of either ferrous or ferric iron, and 2 others were given the same amount of iron, but as a complex with desferrioxamine. Other studies were performed on dogs to evaluate the effect of desferrioxamine on arterial blood pressure and the toxicity of the iron-desferrioxamine complex.Results. Rapid intravenous infusion produced hypotension in two children, one of whom had a seizure. Significant amounts of iron were discovered in the urine of all patients. None had progression of symptoms while in the hospital. One child who was in coma when admitted was noted to be developmentally retarded 5 months later.All 14 control dogs died by 10 hours after duodenal instillation of iron. Three of the dogs treated survived, but these were the three with the lowest pretreatment iron levels. The enteral administration of lethal doses of iron previously complexed with desferrioxamine resulted in the excretion of large amounts of iron in the urine in 4 dogs and in one of three children treated with moderate amounts of iron complexed with desferrioxamine. The children were not affected adversely by this treatment, but the dogs experienced a marked drop in blood pressure and died within a few hours.Conclusions. The use of desferrioxamine results in the rapid excretion of more iron in the urine than would occur without such treatment. The drug produces hypotension when administered rapidly by parenteral infusion. The enteral administration of the drug to poisoned dogs or children does not prevent the absorption of iron; indeed the complex is freely absorbable. The desferrioxamine–iron complex is toxic to the kidneys.COMMENTARY
Title: Studies in Acute Iron Poisoning. I. Desferrioxamine in the Treatment of Acute Iron Poisoning: Clinical Observations, Experimental Studies, and Theoretical Considerations, by Charles F. Whitten et al,Pediatrics, 1965;36:322–335; andStudies in Acute Iron Po
Description:
Objective.
Children with iron poisoning, and mongrel dogs studied under laboratory conditions, were evaluated to explore the safety and effectiveness of the use of desferrioxamine in acute iron intoxication as reported in the 1965 paper.
Methodology.
Twelve children admitted to a pediatric unit after iron ingestion were subjected to gastric lavage (10) and treatment either with intravenous desferrioxamine (9) or with a combination of intravenous and enteral (gavage) desferrioxamine (3).
Serum iron levels before and after therapy, urinary excretion of iron, and symptoms before and after therapy were all measured.
Mongrel dogs (23) were fasted overnight and then given toxic doses of ferrous sulfate intraduodenally under general anesthesia.
Controls (14) were observed for serum iron, arterial pH, and hematocrit, and mean arterial blood pressures.
The 9 dogs treated were given desferrioxamine both intravenously and intraduodenally, whereas the controls were observed without treatment.
Four additional dogs were treated with a lethal dose of iron that was first complexed with desferrioxamine and then administered intraduodenally.
Another 2 dogs received a slow intravenous infusion of either ferrous or ferric iron, and 2 others were given the same amount of iron, but as a complex with desferrioxamine.
Other studies were performed on dogs to evaluate the effect of desferrioxamine on arterial blood pressure and the toxicity of the iron-desferrioxamine complex.
Results.
Rapid intravenous infusion produced hypotension in two children, one of whom had a seizure.
Significant amounts of iron were discovered in the urine of all patients.
None had progression of symptoms while in the hospital.
One child who was in coma when admitted was noted to be developmentally retarded 5 months later.
All 14 control dogs died by 10 hours after duodenal instillation of iron.
Three of the dogs treated survived, but these were the three with the lowest pretreatment iron levels.
The enteral administration of lethal doses of iron previously complexed with desferrioxamine resulted in the excretion of large amounts of iron in the urine in 4 dogs and in one of three children treated with moderate amounts of iron complexed with desferrioxamine.
The children were not affected adversely by this treatment, but the dogs experienced a marked drop in blood pressure and died within a few hours.
Conclusions.
The use of desferrioxamine results in the rapid excretion of more iron in the urine than would occur without such treatment.
The drug produces hypotension when administered rapidly by parenteral infusion.
The enteral administration of the drug to poisoned dogs or children does not prevent the absorption of iron; indeed the complex is freely absorbable.
The desferrioxamine–iron complex is toxic to the kidneys.
COMMENTARY.
Related Results
Overview of acute Chinese medicine poisoning in Hong Kong
Overview of acute Chinese medicine poisoning in Hong Kong
Abstract
Background
Chinese medicine (CM) poisoning is relatively rare in Hong Kong. According to the Department of Healt...
Abnormal Brain Functional Network Dynamics in Acute CO Poisoning
Abnormal Brain Functional Network Dynamics in Acute CO Poisoning
Aims: Carbon monoxide poisoning is a common condition that can cause severe neurological sequelae. Previous studies have revealed that functional connectivity in carbon monoxide po...
Poisoning Patterns, Causes, and Implications for Hospital-Centric Interventions- A Retrospective Single-Centre Observational Study from India
Poisoning Patterns, Causes, and Implications for Hospital-Centric Interventions- A Retrospective Single-Centre Observational Study from India
Poisoning poses a significant public health concern in India, with rising trends observed over recent years. The study aims to observe patterns of demographic characteristics, pres...
Treatment outcome and associated factors among patients admitted with acute poisoning in a tertiary hospital in Eastern Ethiopia: A cross-sectional study
Treatment outcome and associated factors among patients admitted with acute poisoning in a tertiary hospital in Eastern Ethiopia: A cross-sectional study
Introduction:
Acute poisoning causes morbidity and mortality worldwide. There is scarce of information on acute poisoning in the study area.
...
Book Reviews
Book Reviews
Book reviewed in this article:Lohner, Edgar and Hunter G. Hannum. Modern German Brama. New York: Houghton Mifflin, 1966.Durant, Will and Ariel. The Age of Voltaire. New York: Simon...
Family Pediatrics
Family Pediatrics
ABSTRACT/EXECUTIVE SUMMARYWhy a Task Force on the Family?The practice of pediatrics is unique among medical specialties in many ways, among which is the nearly certain presence of ...
MicroRNA-322-5p Protects Against Myocardial Infarction through Targeting BTG2
MicroRNA-322-5p Protects Against Myocardial Infarction through Targeting BTG2
Abstract
Objective: A large cohort of studies have addressed the therapeutic importance of microRNA (miR) in the treatment of myocardial infarction (MI). The current paper ...
Prospective Comparison on Cardiac Iron and Liver Iron by MR In Thalassemia Major Patients Treated with Combination Deferipron–Desferrioxamine Versus Deferipron and Desferrioxamine In Monoterapy
Prospective Comparison on Cardiac Iron and Liver Iron by MR In Thalassemia Major Patients Treated with Combination Deferipron–Desferrioxamine Versus Deferipron and Desferrioxamine In Monoterapy
Abstract
Abstract 5164
Introduction:
Using T2* MR a randomised placebo controlled study from Sardinia demonstrate...

